This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
SUMMARY
- The active ingredient in CAPLYTA is lumateperone. Lumateperone is an atypical antipsychotic present as lumateperone tosylate salt.1
- Each capsule contains:
- 42 mg of lumateperone (equivalent to 60 mg of lumateperone tosylate), or
- 21 mg of lumateperone (equivalent to 30 mg of lumateperone tosylate), or
- 10.5 mg of lumateperone (equivalent to 15 mg of lumateperone tosylate).
- The capsules include the following inactive ingredients: croscarmellose sodium, gelatin, magnesium stearate, mannitol, and talc.
- Colorants include FD&C blue #1 and red #3 (42 mg), FDA/E172 black iron oxide, FDA/E172 red iron oxide and FD&C red #3 (10.5 mg), and titanium dioxide (42 mg, 21 mg and 10.5 mg).
product packaging
- CAPLYTA capsules are available in three strengths:1
- 42 mg: Blue cap and opaque white body imprinted with “ITI-007 42 mg”
- 21 mg: Opaque white cap and body imprinted with “ITI-007 21 mg”
- 10.5 mg: Opaque light pink cap and body imprinted with “ITI-007 10.5 mg”